Democratic Bill Would Require Disclosure of Pharma R&D Expenditures
House and Senate Democrats on April 7, 2022, introduced legislation requiring publicly traded drug makers to make new disclosures around …
Sen. Toomey Releases Draft Stablecoin Framework
Sen. Pat Toomey on April 6, 2022, rolled out draft legislation setting out a three-path regulatory framework for stablecoins. Toomey, …
Investors Applaud SEC Stance on Accounting Treatment of Customers’ Cryptos as Commissioner Peirce Criticizes It
A group of investors wants the SEC not to be deterred by strong pushback from the crypto industry against the …
Senate Republicans Release ‘JOBS Act 4.0 Deregulatory Package
Senate Republicans on April 4, 2022, rolled out draft legislation to further ease regulatory requirements for entrepreneurs, retail investors, public …
Critics Press for Reform as SEC Fails to Separate Enforcement and Adjudicatory Functions
The SEC disclosed that a number of years ago, an internal control failure allowed its staff to breach a supposed …
New SEC Staff Guidance Covers Platform Accounting for Crypto-Asset Safeguards
The SEC published Staff Accounting Bulletin (SAB) No. 121 to provide the staff’s views about the accounting for obligations to safeguard crypto …
AICPA and NASBA Gain Official Observer Status on PCAOB’s New Advisory Group
When the PCAOB finalized the charters of its two new advisory groups, it decided to add the AICPA’s Auditing Standards …
SEC Seeks Funding for 400 New Positions
The SEC on March 28, 2022, released a Congressional budget justification document that seeks funding for 400 new positions, 65 …
Bill Seeking Ouster of Russian Officials from IOSCO, FSB Clears House Committee
The House Financial Services Committee on March 17, 2022, unanimously advanced a bill seeking the exclusion of Russian officials from …
House Panel to Weigh Bill Seeking Exclusion of Russian Officials from IOSCO, FSB
The House Financial Services Committee is slated to vote as early as March 17, 2022, on a slate of bills …